Showing results (31-40 of 319) with videos related to
Sort By:
Pageof 32
Expert Opinion on Biological Therapy|October 24, 2019
Role of immune checkpoint inhibitors in the treatment of colorectal cancer: focus on nivolumabAlexandre A Jácome, Cathy EngCancer Discovery|July 3, 2025
Cancer in the Prime of Life: Etiologic Insights and Supportive Oncologic Interventions for the Rising Burden of Young Adult CancerChristopher G Cann, Cathy EngJournal of the Advanced Practitioner in Oncology|August 5, 2014
Delayed Presentation of DPD Deficiency in Colorectal CancerLindsey Law, Jane Rogers, Cathy EngThe Oncologist|March 23, 2016
The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy ChallengesJane E Rogers, Arvind Dasari, Cathy EngAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The Management and Prevention of Anal Squamous Cell CarcinomaCathy Eng, Craig Messick, Rob Glynne-JonesSurgical Oncology Clinics of North America|May 13, 2004
Chemotherapy and radiation of anal canal cancer: the first approachCathy Eng, James Abbruzzese, Bruce D MinskyExpert Opinion on Emerging Drugs|December 3, 2008
Emerging drugs for colorectal cancerDavid R Fogelman, Scott Kopetz, Cathy EngCurrent Treatment Options in Oncology|June 6, 2022
The Role of Immunotherapy in the Treatment of Anal Cancer and Future StrategiesAlexandre A Jácome, Van Karlyle Morris, Cathy EngJournal of Gastrointestinal Oncology|October 22, 2015
Cetuximab in combination with cisplatin and 5-Fluorouracil induces dramatic response in metastatic refractory squamous cell carcinoma of the anal canalJane E Rogers, Ninoska N Silva, Cathy EngThe Oncologist|December 16, 2023
Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal CanalMichael LaPelusa, Christopher Cann, Kristen K Ciombor, et al.Pageof 32